News Conference News NY Valves 2024 Long-term Mortality After TAVI Lower With DOACs vs VKAs Todd Neale June 06, 2024
News Daily News Another DOAC Fails in the Setting of Mechanical Heart Valves Todd Neale September 28, 2022
News Conference News ACC 2022 ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI Todd Neale April 05, 2022
News Daily News Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality Michael O'Riordan March 10, 2022
News Conference News ESC 2021 ENVISAGE-TAVI AF: Edoxaban Disappoints in TAVI Setting Todd Neale August 28, 2021
News Conference News ACC 2021 Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC Michael O'Riordan May 17, 2021
News Conference News ACC 2021 ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI Yael L. Maxwell May 15, 2021
News Conference News TCT 2019 Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA Michael O'Riordan September 28, 2019
News Opinion Conversations in Cardiology Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC? November 16, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2018 Shelley Wood April 02, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2017 Shelley Wood September 30, 2017
News Conference News TVT 2017 Valve Leaflet Thrombosis: Treat It or Leave It Be? Shelley Wood June 19, 2017
News Daily News Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban Michael O'Riordan January 03, 2017
Presentation Apixaban in Patients With Atrial Fibrillation After TAVR Presenter: J. Seeger January 03, 2017
News Daily News Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns Shelley Wood September 13, 2016
News Daily News Riesgo de ACV con TAVR: Una Revisión en Profundidad de los Datos del PARTNER y CoreValve Revela Oportunidades e Incógnitas Shelley Wood September 13, 2016